Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis

Indira Acharya, David S. Weisman, Lanaya Williams Smith, Lois Johanna Arend

Research output: Contribution to journalArticlepeer-review

Abstract

Drug-induced vasculitis can rarely cause inflammation and necrosis of blood vessel walls of both kidney and lung tissue. Diagnosis is challenging because of the lack of difference between systemic and drug-induced vasculitis in clinical presentation, immunological workup and pathological findings. Tissue biopsy guides diagnosis and treatment. Pathological findings must be correlated with clinical information to arrive at a presumed diagnosis of drug-induced vasculitis. We present a patient with hydralazine-induced antineutrophil cytoplasmic antibodies-positive vasculitis with a pulmonary-renal syndrome manifesting as pauci-immune glomerulonephritis and alveolar haemorrhage.

Original languageEnglish (US)
Article numbere254736
JournalBMJ case reports
Volume16
Issue number7
DOIs
StatePublished - Jul 10 2023

Keywords

  • drugs and medicines
  • renal system

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis'. Together they form a unique fingerprint.

Cite this